AXS Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,620
| Closed | -$1.31M | – | 200 |
|
|
2025
Q1 | $1.31M | Sell |
51,620
-964
| -2% | -$24.4K | 0.36% | 123 |
|
|
2024
Q4 | $1.4M | Sell |
52,584
-46,018
| -47% | -$1.22M | 0.39% | 100 |
|
|
2024
Q3 | $2.85M | Buy |
+98,602
| New | +$2.85M | 0.76% | 23 |
|
|
2024
Q1 | – | Sell |
-2,426
| Closed | -$69.8K | – | 387 |
|
|
2023
Q4 | $69.8K | Sell |
2,426
-35,176
| -94% | -$1.01M | 0.02% | 350 |
|
|
2023
Q3 | $1.25M | Buy |
37,602
+3,648
| +11% | +$121K | 0.32% | 96 |
|
|
2023
Q2 | $1.25M | Buy |
33,954
+2,016
| +6% | +$73.9K | 0.33% | 113 |
|
|
2023
Q1 | $1.3M | Buy |
31,938
+5,939
| +23% | +$242K | 0.43% | 66 |
|
|
2022
Q4 | $1.33M | Sell |
25,999
-409
| -2% | -$21K | 0.48% | 58 |
|
|
2022
Q3 | $1.16M | Buy |
26,408
+1,236
| +5% | +$54.1K | 0.45% | 55 |
|
|
2022
Q2 | $1.32M | Buy |
25,172
+17,533
| +230% | +$919K | 0.47% | 49 |
|
|
2022
Q1 | $395K | Sell |
7,639
-5,135
| -40% | -$266K | 0.16% | 99 |
|
|
2021
Q4 | $754K | Buy |
+12,774
| New | +$754K | 0.18% | 95 |
|
|
2021
Q3 | – | Sell |
-22,158
| Closed | -$868K | – | 189 |
|
|
2021
Q2 | $868K | Buy |
22,158
+1,572
| +8% | +$61.6K | 0.26% | 85 |
|
|
2021
Q1 | $746K | Buy |
+20,586
| New | +$746K | 0.27% | 87 |
|